AHR and prostate carcinoma: The obtained results suggested that the presence of AhR inhibits prostate carcinogenesis, and the model of prostate cancer development based on the genotype of the mice was as follows: AhR+/+ < AhR+/− < AhR−/−, where AhR+/+ mice had the lowest incidence of prostate cancer development compared to AhR−/− mice (16% vs. 60%) [18].